Development of Frailty Prevention Clinic in Geriatric Comprehensive Clinic RSCM: The Role of Resistance Training as Sarcopenia and Frailty Management Towards Frailty Score, Sarcopenia Score, and Quality of Life
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Frailty
- Sponsor
- Indonesia University
- Enrollment
- 220
- Locations
- 1
- Primary Endpoint
- Frailty Status
- Last Updated
- 3 years ago
Overview
Brief Summary
There is an increasing number of elderly population, not only in Indonesia, but also in the world. With increasing of age, there is also an increasing number of elderly with sarcopenia and frailty. Both of the diseases can lead to dependency, decrease quality of life, and morbidity. Besides nutrition, physical activity, especially resistance training is proven to be beneficial in improving sarcopenia and frailty condition.
Currently in Cipto Mangunkusumo National Hospital (RSCM), there is no comprehensive frailty prevention clinic in the geriatric inpatient clinics. This research can be the base of frailty and sarcopenia treatment in RSCM.
Investigators
Siti Setiati
Prof
Indonesia University
Eligibility Criteria
Inclusion Criteria
- •Patients 60 years old or orlder
- •Categorized as Pre-frail or Frail based on FRAIL criteria
- •Is not in routine physical activity in the past 3 months
- •Succeeded Mini Physical Performance Test with score 11 or more
Exclusion Criteria
- •Cognitive Disturbance (Abbreviated Mental Test \< 8)
- •Not consenting to join the trial
Outcomes
Primary Outcomes
Frailty Status
Time Frame: 12 weeks
The FRAIL scale includes 5 components: Fatigue, Resistance, Ambulation, Illness, and Loss of weight (10). Frail scale scores range from 0-5 (i.e., 1 point for each component; 0=best to 5=worst) and represent frail (3-5), pre-frail (1-2), and robust (0) health status
Sarcopenia Status
Time Frame: 12 weeks
Measured using: * BIA: \<7.0 kg/m2 in men and \<5.7 kg/m2 in women * Five times sit to stand: ≥12 seconds * Hand-grip strength: \<28 kg for men and \<18 kg for women
Walking Speed
Time Frame: 12 weeks
\<1.0 m/s
Patient's Quality of Life
Time Frame: 12 weeks
Measured by EQ-5D: ranging from 0 ('worst imaginable health') to 100 ('best imaginable health')
Secondary Outcomes
- Prevalence of Frailty(12 weeks)
- Prevalence of Sarcopenia(12 weeks)